• International Journal of Industrial Entomology and Biomaterials
• /
• 제24권2호
• /
• pp.63-68
• /
• 2012

Osteoporosis is characterized by the reduced density of mineralized bone matrix. The loss of bone has been attributed to an imbalance between bone formation and bone resorption. The silkmoth is one of the famous traditional tonic medicines. Silkworm pupa was evaluated for its antiosteoporotic activity in an ovariectomized rat model of osteoporosis. The rats were ovariectomized at 6weeks of age and divided into 7 groups. All the groups were fed without calcium diet. The OVX rats were treated with water and silkworm powder for 6 weeks. In OVX rats, the body weight, feeding and water intake quantity did not show a significant change, but the silkworm pupa powder immediately before the eclosion of Yeonrokjam was significantly increased the bone mineral density in the femoral bone. The silkworm pupa powder increased the bone with increasing calcium in serum. These results also showed its protective action through promotion of bone formation. The silkworm pupa powder has a definite antiosteoporotic effect; similar to estrogen, it is especially effective for the prevention of bone fracture induced by estrogen deficiency. The silkworm pupa powder is a promising anti-osteoporotic agent that can prevent bone fractures in osteoporotic patients. The silkworm pupa powder does not show serious side effects because natural herbal medicine origin.

• Journal of Korean Neurosurgical Society
• /
• 제37권2호
• /
• pp.116-123
• /
• 2005

Objective: Percutaneous kyphoplasty using a balloon-catheter is an widely accepted method which achieves the restoration of vertebral height and the correction of kyphotic deformity with little complication in osteoporotic vertebral compression fractures. The authors assess the results of 59 patients who underwent kyphoplasty, and analyze the factors that could affect the prognosis. Methods: From December 2001 to May 2003, fifty-nine patients underwent kyphoplasty. The patients included 49 women and 10 men aged 52-85 years. Average t-score on bone marrow density was -3.58. About 7cc of polymethylmethacrylate(PMMA) was injected into the fractured vertebral body using $Kyphon^{(R)}$ under local anesthesia. The vertical height of all fractured vertebrae was measured both before and after surgery. Outcome data were obtained by comparing pre- and post-operative VAS score and by assessing postoperative satisfaction, drug dependency and activity. Various clinical factors were analyzed to assess the relationship with the outcome. Results: The VAS score improved significantly, and the mean percentage of restored vertebral height was 53%. The mean improvement in kyphosis was $3.6^{\circ}$. Eighty-nine percent of the patients gained excellent or good results. Any of the clinical factors including the interval between fracture and operation, the degree of height loss, the degree of the vertebral height restoration or the correction rate of kyphosis did not affect the clinical results. Conclusion: Kyphoplasty is associated with a statistically significant improvement in pain and function with little complication. The clinical results are not affected by any clinical parameters. Further follow-up study is needed to determine whether the restoration affects the long-term clinical results.

• Journal of Korean Neurosurgical Society
• /
• 제47권3호
• /
• pp.199-202
• /
• 2010

Objective : Balloon kyphoplasty is a minimally invasive procedure that is mainly performed for refractory pain due to osteoporotic compression fractures. The purpose of this study was to evaluate the results of balloon kyphoplasty performed at different times after an injury. Methods : In this retrospective study, the records of 99 patients who underwent one level of balloon kyphoplasty between January 2005 and December 2007 were reviewed. The patients were divided into three groups : 21 patients treated within 3 weeks of an injury (the acute group), 49 treated within 3 weeks to 2 months of an injury (the subacute group), and 29 patients treated at more than 2 months after an injury (the chronic group). Clinical outcomes were assessed using a visual analogue scale (VAS). In addition, modified MacNab's grading criteria was used to assess the subjective patient outcome. The radiology findings, including vertebral height restoration and procedure related complications, were analyzed based on the different time intervals after the injury. Results : Patients in all three groups achieved marked pain relief in terms of the VAS within 7 days of the procedure. Good or excellent results were achieved by most patients in all three groups. However, the height restoration, the main advantage to performing a balloon kyphoplasty, was not achieved in the chronic group. Moreover, evidence of complications including cement leakage was observed significantly less frequently in the subacute group compared to the other two groups. Conclusion : Although balloon kyphoplasty is an effective treatment for osteoporotic compression fractures, with regard to pain relief, the subacute stage appears to be optimal for treating patients with a balloon kyphoplasty in terms of achieving the best outcomes with minimal complications.

• 대한정형외과학회지
• /
• 제54권2호
• /
• pp.187-191
• /
• 2019

척추 경막외 혈종은 자연적으로 혹은 외상에 의해 발생할 수 있으며 혈관구조 이상이나 응고장애의 기저질환을 갖고 있는 환자에서 호발한다. 대부분의 척추 경막외 혈종은 명확한 이유 없이 자연적으로 발생하며 외상에 의해 발생하는 경막외 혈종은 전체 척추 손상의 1.0%-1.7% 미만으로 흔하지 않다. 저 에너지 손상에 의한 골다공증성 척추 압박골절 이후 지연성으로 발생한 척추 경막외 혈종이 마미증후군을 일으키는 사례는 드물게 보고되고 있다. 저자들은 고령에서 저 에너지 손상에 의한 척추 압박골절로 인해 지연성으로 혈종발생 후 마미증후군이 발생한 사례를 경험하였고 아직 국내에 보고된 사례가 없어 이를 문헌 고찰과 함께 보고하고자 한다.

• Clinics in Shoulder and Elbow
• /
• 제16권1호
• /
• pp.33-39
• /
• 2013

목적: 고령 환자의 상완골 원위부 골절에서 이중 강선 장력대 고정술을 이용한 수술의 임상적 결과를 분석하여 그 유용성을 알아보고자 한다. 대상 및 방법: 상완골 원위부 골절 환자 중 AO 분류상 C형 골절과 골다공증을 가진 65세 이상의 고령 환자에서 이중 강선 장력대 고정술을 이용해 관혈적 정복과 내고정을 시행 받은 10예를 대상으로 하였다. 남자가 1명, 여자가 9명이었으며 평균 연령은 74.6(66~84)세였다. 평균 추시 기간은 39.2(20~74)개월이었다. 골유합 유무, 시기와 주관절의 운동 범위를 측정하였고, Mayo 주관절 수행 점수, Jupiter 등에 의한 평가법을 이용하여 기능 상태를 평가하였다. 결과: 골유합은 10명에서 2차적인 전위 없이 이루어졌고, 평균 골유합 기간은 16.6(13~22)주였다. 최종 추시시 측정한 평균 주관절 운동범위는 굴곡 구축은 8.5 (0~15)도, 후속 굴곡 119(100~140)도, Mayo 주관절 수행 점수는 82(70~90)점으로 각각 우수 2예(20%), 양호 7예(70%), 보통 1예(10%)였다. Jupiter 등에 의한 평가법을 따르면 각각 우수 7예(70%), 양호 1예(10%), 보통 2예(20%)였다. 1예에서 이소성 골화가 있었으나 그에 따른 증상은 동반되지 않아 추시 관찰하기로 하였으며, 1예에서 강선에 대한 피부 자극 증상이 발생하여 장력대 강선 교체 수술을 시행하였다. 결론: 골다공증을 가진 고령 환자의 상완골 원위부 C형 골절의 수술적 치료에서 이중 강선 장력대 고정술은 견고한 고정과 동시에 조기 관절 운동을 가능하게 하여 효과적이며 우수한 치료법으로 사료된다.

• 여성건강간호학회지
• /
• 제15권4호
• /
• pp.344-352
• /
• 2009

Purpose: The study was to identify influencing factors on fear of falling in postmenopausal women. Methods: With a correlational survey design, 125 postmenopausal women were recruited at the D metropolitan city by a convenience sampling. Fracture risk status was assessed by bone mineral densities (BMD) at lumbar and femur with DEXA method. A structured study questionnaire was used to measure demographic variables, osteoporosis self-efficacy, and fear of falling. Results: Mean age of the subjects was 59 years old and duration since menopause was 9.55 years. Twenty six percent of the subjects belonged to osteoporotic group in fracture risk status. Mean score for fear of falling was 16.10 (SD=5.18) indicating low level, and osteoporosis self-efficacy for exercise and diet was 44.76 (SD=7.41), indicating mid-range level. Factors influencing the fear of falling was longer time since menopause ($\beta=.30$), lower score of osteoporosis self-efficacy for exercise ($\beta=-.26$), poor health perception status ($\beta=-.16$), and presence of chronic disease ($\beta=.16$), and the explained variance was 20%. Conclusion: Although the level of fear of falling was yet low in postmenopausal women, women who had lower self-efficacy of osteoporosis for exercise and poorer health perception felt greater fear of falling. Therefore, an educational program specific to improve osteoporosis self-efficacy and reduce the fear of falling is needed for improving postmenopausal women's psychosocial well-being.

• Journal of Korean Neurosurgical Society
• /
• 제47권4호
• /
• pp.278-281
• /
• 2010

Objective : For the treatment of osteoporotic vertebral compression fracture, percutaneous vertebroplasty (PVP) is currently widely used as an effective and relatively safe procedure. However, some patients do not experience pain relief after PVP. We performed several additional PVP procedures in those patients who did not have any improvement of pain after their initial PVP and we obtained good results. Our purpose is to demonstrate the effective results of an additional PVP procedure at the same previously treated level. Methods : We reviewed the medical records and the radiologic data of the PVP procedures that were performed at our hospital from November 2005 to May 2008 to determine the patients who had undergone additional PVP. We identified ten patients and we measured the clinical outcomes according to the visual analogue scale (VAS) score and the radiologic parameters, including the anterior body height and the kyphotic angulation. Results : The mean volume of polymethylmethacrylate injected into each vertebrae was 4.3 mL (range: 2-8 mL). The mean VAS score was reduced from 8 to 2.32. The anterior body height was increased from 1.7 cm to 2.32 cm. The kyphotic angulation was restored from 10.14 degrees to 2.32 degrees. There were no complications noted. Conclusion : The clinical and radiologic outcomes suggest that additional PVP is effective for relieving pain and restoring the vertebral body in patients who have unrelieved pain after their initial PVP. Our study demonstrates that additional PVP performed at the previously-treated vertebral levels could provide therapeutic benefit.

• 대한의용생체공학회:의공학회지
• /
• 제23권6호
• /
• pp.451-458
• /
• 2002

골다공증이란 골량의 감소에 의해 야기되며. 해면골 미세구조의 골밀도가 감소하는 질병이다. 약물치료(부갑상선 호르몬)법은 골소주의 두께 및 골의 강도를 어느 정도 증가시킬 수 있는 호르몬 치료법이다. 척추성형술은 골다공성 척추 압박 골절의 치료를 위하여 척추 해면골에 주사기를 통하여 골 시멘트를 주입하는 최소 침습적 수술법이다. 임상적으로 골 시멘트의 물성치에 영향을 미치더라도 점성 감소와 주입 시간 확보를 위해 중합비율을 변경하여 사용한다. 본 연구의 목적은 골 시멘트 중합비율 변경에 따른 척추 해면골의 역학적 특성을 알아보고자 한다. 본 논문에서 는 수정된 보로노이 도형을 이용하여 척추 해면골의 유한요소 모델을 생성하고, 골 시멘트의 중합비율(0.40~l.07$m\ell$/g)에 따른 척추 해면골의 강도회복 정도를 비교하였다. 또한 골다공증 치료에서 호르몬 치료와 골 시멘트 치료의 상대적인 영향을 비교 분석하였다. 분석결과 골 시멘트 치료모델의 탄성계수와 강도는 정상 상태의 약 50%로 회복되었으며, 이 값은 호르몬 치료 모델의 약 2배이다. 0.53$m\ell$/g의 중합비율에서 골 시멘트의 탄성계수와 강도가 최고이며 1.07$m\ell$/g의 중합비율에서 최소의 탄성계수와 강도(각각 42%와 49%)이지만 약물 치료보다는 더 효과적임을 알 수 있다. 척추성형술시 제작사에서 추천하는 중합비율과 다른 비율을 사용할 경우 골 시멘트의 물성치 감소뿐만 아니라 환자의 골 밀도에 따라서 해면골의 강도회복에 문제가 발생할 수 있다는 것을 알 수 있었다.

• Genomics & Informatics
• /
• 제9권2호
• /
• pp.52-58
• /
• 2011

Osteoporotic fracture (OF), along with bone mineral density (BMD), is an important diagnostic parameter and a clinical predictive risk factor in the assessment of osteoporosis in the elderly population. However, a genome-wide association study (GWAS) on OF has not yet been clarified sufficiently. To identify OF-associated genetic variants and candidate genes, we conducted a GWAS in a population-based cohort (Korean Association Resource [KARE], n=1,427 [case: 288 and control: 1139]) and performed a de novo replication study in hospital-based individuals (Asan and Catholic Medical Center [ACMC], n=1,082 [case: 272 and control: 810]). In a combined meta-analysis, a newly identified genetic locus in an intergenic region at 10p11.2 (near genes FZD8 and ANKRD30A ) showed the most significant association (odd ratio [OR] = 2.00, 95% confidence interval [CI] = 1.47~2.74, p=$1.27{\times}10^{-6}$) in the same direction. We provide the first evidence for a common genetic variant influencing OF and genetic information for further investigation in bone metabolism.

• 동의생리병리학회지
• /
• 제26권2호
• /
• pp.160-165
• /
• 2012

Osteoporotic fracture became a serious social problem, which related with mortality and morbidity in old age population. Osteoclast which is responsible for bone resorption is originated from hematopoietic cell line and plays a key role osteoporotic bone loss. Cynanchum wilfordii (Asclepiadaceae) roots have been used in Korean folk medicine for the treatment of diabetes mellitus and aging progression. Also, recent studies have shown that the extract and fractions of Cynanchi Wilfordii Radix have various pharmacological actions including scavenging free radicals, enhancing immunity, reducing high serum cholesterol, and anti-tumor activity. However, the effect of extract of Cynanchi Wilfordii Radix in osteoclast differentiation had not been reported. Thus, we evaluated the effect of Cynanchi Wilfordii Radix on receptor activator of nuclear factor-${\kappa}B$ ligand (RANKL)-induced osteoclast differentiation. Through our study, we found that Cynanchi Wilfordii Radix significantly inhibited osteoclast differentiation induced by RANKL. Cynanchi Wilfordii Radix suppressed the activation of p38 pathway and $NF{\kappa}B$ in bone marrow macrophages (BMMs) treated with RANKL. Also, Cynanchi Wilfordii Radix significantly inhibited the mRNA expression of c-Fos, tartrate-resistant acid phosphatase (TRAP), osteoclast-associated receptor (OSCAR), nuclear factor of activated T cells (NFAT)c1 and cathepsin K in BMMs treated with RANKL. Particularly, Cynanchi Wilfordii Radix inhibited the protein expression of c-fos and NFATc1. Taken together, our results demonstrated that Cynanchi Wilfordii Radix may be useful treatment option of bone-related disease such as osteoporosis leads to fracture of bone and rheumatoid arthritis.